| Student’s Name |
Graduation Year |
Degree |
Abstracts |
Research Name |
| Levites Yona |
2002 |
PhD |
Abstracts |
Molecular Events in Dopaminergic Neurodegeneration; Mechanism of Neuroprotective Action of Major Green Tea Polyphenol, (-)-Epigallocatechin-3- Gallate |
| Liu Wei |
2016 |
PhD |
Abstracts |
Development of Novel Multifunctional Cholinesterase/ Monoamine Oxidase Inhibitors as Derivatives of Rivastigmine and Rasagiline for Treatment of … |
| Golko Sagit |
2016 |
PhD |
Abstracts |
Novel Therapeutic Approach of the Protective Multi-Target Iron Chelating Compound Combined with Enriched Diet in Mouse Model of Amyotrophic Lateral Sclerosis |
| Rozenfeld Danit |
2013 |
PhD |
Abstracts |
Molecular Neuroprotective Targets of the Novel Multi- Functional Iron-Chelating Drug, M30, in Experimental Models of Type 2 Diabetes Mellitus & Alzheimer’s Disease |
| Maoz Eyla-Hagar |
2013 |
PhD |
Abstracts |
Targeting Glutamatergic Excitotoxic Damage and Mitochondria by the Novel Multi-Target Neurorestorative Drug HLA20 |
| Kupershmidt Lana |
2012 |
PhD |
Abstracts |
The Neuroprotective Activity of Novel Multi-Functional,Brain -Permeable Iron Chelators in Experimental Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging |
| Fishma-Jacob Tali |
2011 |
PhD |
Abstracts |
A Sporadic Parkinson’s Disease Model via Silencing of the Ubiquitin-Proteasome/E3-Ligase Component, SKP1A |
| Drigues Noam |
2010 |
PhD |
Abstracts |
Rat Hippocampal Gene Expression after Chronic Administration of Antidepressant Drugs Employing cDNA Microarray |
| Danovich Ilana |
2010 |
PhD |
Abstracts |
The Molecular Mechanism of Pharmacodynamic Interactions between Psychoactive Drugs: Interactions between Antidepressants and Antipsychotic Drugs |
| Avramovich-Tirosh Yael |
2009 |
PhD |
Abstracts |
Neuroprotective/Neurorescue Mechanisms and Processing of the Alzheimer’s Disease APP by Novel Multi- Functional Iron-Drugs |
| Reznichenko Lydia |
2008 |
PhD |
Abstracts |
Neurorescue Mechanisms of the Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) in Cell Culture and Animal Models of Neurodegeneration |
| Kalfon Limor |
2008 |
PhD |
Abstracts |
Molecular Mechanisms and Signaling Pathways Mediating the Neuroprotective Action of the Green Tea Polyphenol (-)-Epigallocatechin 3-Gallate (EGCG) |
| Ben-Ari Shunit |
2008 |
PhD |
Abstracts |
Novel Multi-Functional Neuroprotective and Neurorestorative Iron Chelator-Monoamine Oxidase Inhibitor Drugs for Neurodegenerative Diseases |
| Chertkow Yael |
2006 |
PhD |
Abstracts |
The Effects of Typical and Atypical Antipsychotics alone and in Combination with SSRI Antidepressant on Gene and Protein Expression and their Relationship to Clinical… |
| Yogev-Falach Merav |
2006 |
PhD |
Abstracts |
Amyloid Precursor Protein Processing and Neuroprotection by the Anti-Alzheimer’s Drug, Ladostigil (TV3326) |
| Sagi Yotam |
2005 |
PhD |
Abstracts |
Pharmacological and Molecular Mechanisms of Neuroprotective Action of anti-Alzheimer’s and anti Parkinson’s Drugs Ladostigil (TV3326), TV3279, and Rasagiline |
| Grunblatt Edna |
2001 |
PhD |
|
Effect of Neuroprotective Drugs on Gene Expression in MPTP Mice Model of Parkinson’s Disease |
| Lamensdorf Iscak |
1996 |
PhD |
|
Effects of Chronic Treatment with Selective Monoamine Oxidase B Inhibitors (MAO-B) on Dopamine Metabolism in the Striatum |
| Tovi Avi |
1993 |
PhD |
|
The Effects of Iron Deficiency on Metabolism of Neurotransm |
| Yadid Gal |
1991 |
PhD |
|
Biochemical and Pharmacological Rolf of Glyine in Chromaffi |
| Bick Tova |
1989 |
PhD |
|
The Effect of the Pulsatile Secretion of Growth Hormone |
| Badinter Felix |
2015 |
MSc |
Abstracts |
Neuroprotective Effects of the Anti-Parkinsonian Drug Rasagiline and its Major Metabolite 1-(R)- Aminoindan in Animal Models of Aging |
| Avramovich-Tirosh Yael |
2002 |
MSc |
Abstracts |
The Role of Inflammatory Processes in Neurodegeneration, and Prospects for Neuroprotection with Anti- inflammatory Drugs |
| Einoch Amor Reef |
2014 |
MSc |
Abstracts |
The Involvement of BDNF-CREB Signaling Pathways in the Pharmacological Mechanism of Combined SSRI- Antidepressants and Antipsychotics in Schizophrenia |
| Kleiner Yana |
2009 |
MSc |
Abstracts |
Cardioprotective Efficacy of TVP1022 and other Propargylamines |
| Arraf Zaher |
2008 |
MSc |
Abstracts |
Neuroprotective Properties of Lithium in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Mouse Model of Parkinson’s Disease |
| Oren May Meirav |
2006 |
MSc |
Abstracts |
Neuroprotection by the Novel Iron Chelator, M30, in Neurodegeneration Model Induced by Kainic Acid |
| Chillag-Talmor Orly |
2005 |
MSc |
Abstracts |
Neuroprotective Pathways Initiated by Rasagiline: Involvement of PKC in Association with Bcl-2 Family Proteins |
| Reick Avraham |
1997 |
MSc |
|
Neurobiological Aspects of Oxygen and Nitric Oxide Free Radicals |
| Eshel Galia |
1994 |
MSc |
|
The Role of Iron Chelation in the Deceleration – Cell |
| Avnon Yehoudith |
1994 |
MSc |
|
Effect of Intraventric Iron Injection on the Dopaminergic |
| Avigdor Sophie |
1990 |
MSc |
|
The Effect of Smoking During Pregnoncy on Human Plaental |
| Hertz Pnina |
1989 |
MSc |
|
Direct Effects of Sex Steroids on Growth Hormone Secretion |
